Andrew Booth serves as Executive at AbCellera Biologics Inc., where they oversee executive responsibilities. Since joining the company, Andrew Booth has executed 12 insider transactions totaling $32.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 1, 2026 involved receiving (via award) 808,898 shares valued at $0.
Andrew Booth currently holds 8,751,849 shares of AbCellera Biologics Inc. (ABCL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Booth has been a net seller of ABCL stock. They have purchased $1.6M and sold $30.6M worth of shares.
Andrew Booth's most recent insider trade was on Jan 1, 2026, when they sold 808,898 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.85 |
| Discretionary |
| Dec 20, 2022 | ABCL | $9.5K | Option Exercise | 50,000 | $0.19 | Discretionary |
| Dec 20, 2022 | ABCL | $0 | Gift | 50,000 | $N/A | Discretionary |
| May 12, 2022 | ABCL | $492.1K | Purchase | 85,000 | $5.79 | Discretionary |
| Dec 10, 2021 | ABCL | $0 | Gift | 500,000 | $N/A | Discretionary |
| Dec 10, 2021 | ABCL | $160.0K | Option Exercise | 500,000 | $0.32 | Discretionary |
| Nov 11, 2021 | ABCL | $788.6K | Purchase | 53,500 | $14.74 | Discretionary |
| Nov 11, 2021 | ABCL | $204.5K | Purchase | 14,000 | $14.61 | Discretionary |
| Jun 9, 2021 | ABCL | $30.6M | Sale | 1,200,000 | $25.50 | Discretionary |
| Jun 7, 2021 | ABCL | $192.0K | Option Exercise | 600,000 | $0.32 | Discretionary |
| Jun 7, 2021 | ABCL | $114.0K | Option Exercise | 600,000 | $0.19 | Discretionary |